Cardiometabolic multimorbidity is common among patients with psoriasis and is associated with poorer outcomes compared to those without comorbidity Article

author list

  • Enos, Clinton W.; Ramos, Vanessa L.; McLean, Robert R.; Lin, Tin-Chi; Foster, Nicole; Dube, Blessing; Van Voorhees, Abby S.

publication date

  • July 5, 2022


published in



  • Psoriasis
  • biologic therapy
  • biologics
  • comorbid disease
  • metabolic disease
  • multimorbidity
  • outcomes
  • psoriatic disease
  • treatment response